Zobrazeno 11 - 20
of 162
pro vyhledávání: '"Nanda Kerkar"'
Autor:
Michael P. Manns, Cara L. Mack, Mouaz Alsawas, David H. Adams, David N. Assis, M.J. Mayo, John M. Vierling, Albert J. Czaja, Nanda Kerkar, Mohammad Hassan Murad
Publikováno v:
Hepatology. 72:671-722
Autor:
Bernadette Vitola, Christine K. Lee, Nanda Kerkar, Trevor J. Laborda, Kathleen M. Loomes, Kaija-Leena Kolho, Saeed Mohammed, Madeleine Aumar, Kathleen B. Schwarz, Alexandre Rodrigues Ferreira, Binita M. Kamath, Bart G. P. Koot, Cara L. Mack, Annemarie Broderick, Venna L. Venkat, Katryn N. Furuya, Mary Elizabeth M. Tessier, Girish S. Rao, Mercedes Martinez, Marek Woynarowski, Eleonora Druve Tavares Fagundes, Atsushi Tanaka, Tamir Miloh, Pamela L. Valentino, Laura G. Draijer, Douglas Mogul, Mark Deneau, Vratislav Smolka, Nitika A. Gupta, Amanda Ricciuto, Emily R. Perito, Melissa Zerofsky, Nadia Ovchinsky, Simon Horslen, Maureen M. Jonas, Kyung Mo Kim
Publikováno v:
Hepatology, 74(4), 2047-2057. John Wiley and Sons Ltd
Hepatology
Hepatology
Background and Aims Recurrent primary sclerosing cholangitis (rPSC) following liver transplant (LT) has a negative impact on graft and patient survival; little is known about risk factors for rPSC or disease course in children. Approach and Results W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb28e12c988d05385a8817b747a5af76
https://pure.amc.nl/en/publications/recurrence-of-primary-sclerosing-cholangitis-after-liver-transplant-in-children-an-international-observational-study(aab082d4-579e-4631-b00a-f340eb7d2081).html
https://pure.amc.nl/en/publications/recurrence-of-primary-sclerosing-cholangitis-after-liver-transplant-in-children-an-international-observational-study(aab082d4-579e-4631-b00a-f340eb7d2081).html
Autor:
Liting Li, Jian-She Wang, Ozlem Durmaz, Felipe Ordonez, Wikrom Karnsakul, Seema Alam, Cristina Targa Ferreira, Natural Course, Bettina E. Hansen, Kyung Mo Kim, Etienne Sokal, Ryan T. Fischer, Valerie Sency, Estella M. Alonso, Simon Horslen, Elisa de Carvalho, Piotr Czubkowski, Emanuele Nicastro, Nanda Kerkar, Dieter C. Broering, Björn Fischler, Dorothee Krebs-Schmitt, Kathleen M. Loomes, Dominique Debray, Marianne Hørby Jørgensen, Benjamin L. Shneider, Emmanuel Gonzales, Cigdem Arikan, Nathalie Rock, Antal Dezsőfi, Tassos Grammatikopoulos, Steffen Hartleif, Mara Cananzi, Talal Algoufi, Ronald J. Sokol, Jan B F Hulscher, Carolina Jimenez-Rivera, Emmanuel Jacquemin, Anne Spraul, Henkjan J. Verkade, Patryk Lipiński, Daan B E van Wessel, Nejat Mazhar, Maria Rogalidou, Deirdre Kelly, Alexandre Fabre, Daniele Serranti, Pier Luigi Calvo, Yael Mozer-Glassberg, Richard J. Thompson, Cristina Goncalves, Yumirle P. Turmelle, Jesus Quintero Bernabeu, Agustina Kadaristiana, Florence Lacaille, Loreto Hierro, Mohammad Shagrani, Patrick J. McKiernan, Girish S. Rao, Gema Muñoz Bartolo, Huey-Ling Chen, Wendy L. van der Woerd, Irena Jankowska, Amer Azaz, Philip J. Rosenthal, Frederick J. Suchy, Jernej Brecelj, Gabriella Nebbia, Noemie Laverdure, Henrik Arnell, Binita M. Kamath, Heng Wang
Publikováno v:
Hepatology
Hepatology, Wiley-Blackwell, 2021, 74 (2), pp.892-906. ⟨10.1002/hep.31787⟩
Hepatology, 74(2), 892-906. Wiley
Hepatology, Vol. 74, no. 2, p. 892-906 (2021)
Hepatology (Baltimore, Md.)
Hepatology, Wiley-Blackwell, 2021, 74 (2), pp.892-906. ⟨10.1002/hep.31787⟩
Hepatology, 74(2), 892-906. Wiley
Hepatology, Vol. 74, no. 2, p. 892-906 (2021)
Hepatology (Baltimore, Md.)
Mutations in ATP8B1 can lead to familial intrahepatic cholestasis type 1 (FIC1) deficiency, or progressive familial intrahepatic cholestasis type 1 (PFIC1). The rarity of FIC1 deficiency has largely prevented a detailed analysis of its natural histor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ecc4ae32d84b425ddef55c91928639e
https://hal-amu.archives-ouvertes.fr/hal-03663238
https://hal-amu.archives-ouvertes.fr/hal-03663238
Autor:
John C. Magee, Nanda Kerkar, Vicky L. Ng, Benjamin L. Shneider, Kieran Hawthorne, Laura N. Bull, Milton J. Finegold, Ronald J. Sokol, Kathleen M. Loomes, Sarah A. Taylor, Kathleen B. Schwarz, Nitika A. Gupta, Yumirle P. Turmelle, Paula M. Hertel, James E. Squires, Karen F. Murray, Jean P. Molleston, Jorge A. Bezerra, Philip J. Rosenthal, Sehee Kim
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition
Objectives: The aim of the study was to determine the frequency and natural history of infantile idiopathic cholestasis (IC) in a large, prospective, multicenter cohort of infants. Methods: We studied 94 cholestatic infants enrolled up to 6 months of
Autor:
Nanda Kerkar, Cara L. Mack
Publikováno v:
Liver Disease in Children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76437e45527853093acccb4b9a092ac9
https://doi.org/10.1017/9781108918978.020
https://doi.org/10.1017/9781108918978.020
Autor:
Pushpa Sathya, Jessica T. Hochberg, Wael El-Matary, Nadia Ovchinsky, Ruchi Singh, Trevor J. Laborda, Douglas Mogul, Matthew DiGuglielmo, Simon Horslen, Emily R. Perito, Maureen M. Jonas, Alexander Miethke, Bart G. P. Koot, Kathleen B. Schwarz, Girish S. Rao, Nitika A. Gupta, Pamela L. Valentino, Cara L. Mack, Mark Deneau, Katryn N. Furuya, Amanda Ricciuto, M. Kyle Jensen, Laura G. Draijer, Nanda Kerkar, Uzma Shah, Achiya Z. Amir, Stephen L. Guthery, Kathleen M. Loomes, Mercedes Martinez, Tamir Miloh, Andréanne Zizzo, Saeed Mohammad, Christine K. Lee, Bernadette Vitola
Publikováno v:
Hepatology
Background and aims Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on whether these medications improve outcomes. Approach and results We analyz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf3b2ebfb947e045c1ea79b0999907f
https://europepmc.org/articles/PMC8557636/
https://europepmc.org/articles/PMC8557636/
Autor:
Matjaz Homan, Binita M. Kamath, Bart G. P. Koot, Mansi Amin, Parvathi Mohan, Amanda Ricciuto, Melissa Zerofsky, Madeleine Aumar, Kathleen B. Schwarz, Laura G. Draijer, Annemarie Broderick, Kaija-Leena Kolho, Stephen L. Guthery, Nanda Kerkar, Saeed Mohammad, Nisreen Soufi, Alexandra Papadopoulou, Eyal Shteyer, Raffaele Iorio, Nadia Ovchinsky, M. Kyle Jensen, Simon Horslen, Ruchi Singh, Maureen M. Jonas, Kyung Mo Kim, Alexander Miethke, Girish S. Rao, Federica Ferrari, Achiya Z. Amir, Cara L. Mack, Douglas Mogul, Matthew DiGuglielmo, Vratislav Smolka, Christine K. Lee, Pushpa Sathya, Katryn N. Furuya, Nitika A. Gupta, Mercedes Martinez, Atsushi Tanaka, Tamir Miloh, Kathleen M. Loomes, Bernadette Vitola, Uzma Shah, Pamela L. Valentino, Andréanne Zizzo, Mark Deneau, Jessica T. Hochberg, Wael El-Matary, Stacy Moroz, Marcus Auth, Emily R. Perito, Trevor J. Laborda, Marek Woynarowski, Eleonora Druve Tavares Fagundes, Alexandre Rodrigues Ferreira, Raghu Varier, Sirish Palle
Publikováno v:
Hepatology (Baltimore, Md.), 73(3), 1074-1087. John Wiley and Sons Ltd
Paediatrics Publications
Paediatrics Publications
Background and Aims: Disease progression in children with primary sclerosing cholangitis (PSC) is variable. Prognostic and risk-stratification tools exist for adult-onset PSC, but not for children. We aimed to create a tool that accounts for the bioc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637d4623b2b71ae6a097d52eb99df8c2
https://pure.amc.nl/en/publications/the-sclerosing-cholangitis-outcomes-in-pediatrics-scope-index-a-prognostic-tool-for-children(92facea3-8fbb-41d6-adfd-46dfef3c90b7).html
https://pure.amc.nl/en/publications/the-sclerosing-cholangitis-outcomes-in-pediatrics-scope-index-a-prognostic-tool-for-children(92facea3-8fbb-41d6-adfd-46dfef3c90b7).html
Autor:
Cara L. Mack, Robert H Squires, Pinar Bulut, Saul J. Karpen, Ashutosh Gupta, Ravinder Anand, Matthew Ryan, Tamir Miloh, Benjamin L. Shneider, Chuan-Hao Lin, Ronen Arnon, Dennis Black, Pamela L. Valentino, Philip J. Rosenthal, Nanda Kerkar, Shikha S. Sundaram, Estella M. Alonso, Sarah H. Elsea
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 3, Iss 11, Pp 1482-1495 (2019)
Hepatology Communications, Vol 3, Iss 11, Pp 1482-1495 (2019)
Ursodeoxycholic acid (UDCA) is commonly used to treat several liver disorders in adults and children, including primary sclerosing cholangitis (PSC) for which it is not U.S. Food and Drug Administration approved. UDCA treatment has an uncertain impac
Autor:
Nanda Kerkar, Diego Vergani
Publikováno v:
Journal of Autoimmunity. 95:26-33
De novo autoimmune hepatitis (AIH) is an unusual cause of graft dysfunction after liver transplantation. This entity was originally described in 1996 in children transplanted for conditions other than AIH, who developed biochemical and histological f
Autor:
Nanda Kerkar, Rishi Gupta
Publikováno v:
Liver Immunology ISBN: 9783030517083
Biliary atresia, a progressive fibro-inflammatory process that damages the bile ducts, presents in infancy with cholestasis and pale stools. It is the most common indication for liver transplantation in childhood. Gene identification for several chol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40fee9682810f936b320ffb560659d7d
https://doi.org/10.1007/978-3-030-51709-0_28
https://doi.org/10.1007/978-3-030-51709-0_28